Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-11T02:33:42.633Z.
Calculation as of: 2026-09-11T02:33:42.633Z.
Quote observation: 2026-09-10T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8237d54513fe590b1f0ccbf83172440dd636f2ed9cd2551f17e23848d9509eee
PEG RATIO
N/A
DexCom, Inc.
Market Cap
$31.89B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| DexCom, Inc. (DXCM) | $31.89B | N/A |
| ResMed Inc. (RMD)vs › | $31.85B | N/A |
| Biogen Inc. (BIIB)vs › | $31.83B | N/A |
| Centene Corp. (CNC)vs › | $32.31B | N/A |
| Alcon Inc. (ALC)vs › | $32.46B | N/A |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $33.12B | N/A |
| Zoetis Inc. (ZTS)vs › | $30.56B | N/A |
| Waters Corporation (WAT)vs › | $30.04B | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.02B | N/A |
| Medline Inc. (MDLN)vs › | $27.39B | N/A |
PEG Ratio
N/A
P/E Ratio
33.4
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
